GLP-1 drugs like Ozempic linked to weight loss and reduced depression in mice
A new study has found that GLP-1 receptor agonists, the class of drugs that includes Ozempic, produced weight loss and reversed depression-like behavior in mice. The research focuses on the gut-brain axis, the communication pathway between the digestive system and the brain. Scientists believe these drugs may influence mood and mental health by altering gut microbiome signals sent to the brain. The findings add to growing interest in GLP-1 medications beyond their established roles in treating obesity and type 2 diabetes. However, the results are currently limited to animal models, and further research is needed to confirm similar effects in humans.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in